Page 50 - ITPS-6-1

44 INNOSC Theranostics and Pharmacological Sciences, 2023, Vol. 6, No. 1 Hariharan
[6] Reiter, C.D.; Wang, X.; Tanus-Santos, J.E.; Hogg, N.; Cannon, R.O Makani, J.; Younoszai, A.K. Tricuspid Regurgitant Jet Velocity and
3 .; Schechter, A.N.; Gladwin, M.T. Cell-Free Hemoglobin Limits Hospitalization in Tanzanian Children with Sickle Cell Anemia.
rd
Nitric Oxide Bioavailability in Sickle-Cell Disease. Nat. Med., Haematologica. 2014, 99, e1.
2002, 8, 1383–9. [24] Dahoui, H.A.; Hayek, M.N.; Nietert, P.J.; Arabi, M.T.;
[7] Mehari, A.; Gladwin, M.T.; Tian, X.; Machado, R.F.; Kato, G.J. Muwakkit, S.A.; Saab, R.H.; Bissar, A.N.; Jumaa, N.M.;
Mortality in Adults With Sickle Cell Disease and Pulmonary Farhat, F.S.; Dabbous, I.A.; Bitar, F.F.; Abboud, M.R. Pulmonary
Hypertension. JAMA, 2012, 307, 1254–6. Hypertension in Children and Young Adults with Sickle Cell
[8] Parent, F.; Bachir, D.; Inamo, J.; Lionnet, F.; Driss, F.; Loko, G.; Disease: Evidence for Familial Clustering. Pediatr. Blood Cancer,
Habibi, A.; Bennani, S.; Savale, L.; Adnot, S.; Maitre, B.; Yaïci, A.; 2010, 54, 398–402.
Hajji, L.; O’Callaghan, D.S.; Clerson, P.; Girot, R.; Galacteros, F.; [25] Eddine, A.C.; Alvarez, O.; Lipshultz, S.E.; Lipshultz, S.E.;
Simonneau, G. A Hemodynamic Study of Pulmonary Hypertension Kardon, R.; Arheart, K.; Swaminathan, S. Ventricular Structure and
in Sickle Cell Disease. N. Engl. J. Med., 2011, 365, 44–53. Function in Children with Sickle Cell Disease Using Conventional
[9] De Castro, L.M.; Jonassaint, J.C.; Graham, F.L.; Ashley-Koch, A.; and Tissue Doppler Echocardiography. Am. J. Cardiol., 2012, 109,
Telen, M.J. Pulmonary Hypertension Associated with Sickle 1358–64.
Cell Disease: Clinical and Laboratory Endpoints and Disease [26] Forrest, S.; Kim, A.; Carbonella, J.; Pashankar, F. Proteinuria is
Outcomes. Am. J. Haematol., 2008, 83, 19–25. Associated with Elevated Tricuspid Regurgitant Jet Velocity in
[10] Gladwin, M.T.; Sachdev, V.; Jison, M.L.; Shizukuda, Y.; Plehn, J.F.; Children with Sickle Cell Disease. Pediatr. Blood Cancer, 2012,
Minter, K.; Brown, B.; Coles, W.A.; Nichols, J.S.; Ernst, I.; Hunter, 58, 937–40.
L.A.; Blackwelder, W.C.; Schechter, A.N.; Rodgers, G.P.; Castro, [27] Gordeuk, V.R.; Minniti, C.P.; Nouraie, M.; Campbell, A.D.;
O.; Ognibene, F.P. Pulmonary Hypertension as a Risk Factor for Rana, S.R.; Luchtman-Jones, L.; Sable, C.; Dham, N.; Ensing, G.;
Death in Patients with Sickle Cell Disease. N. Engl. J. Med., 2004, Prchal, J.T.; Kato, G.J.; Gladwin, M.T.; Castro, O.L. Elevated
350, 886–95. Tricuspid Regurgitation Velocity and Decline in Exercise Capacity
[11] Ataga, K.I.; Moore, C.G.; Jones, S.; Olajide, O.; Strayhorn, D.; over 22 Months of Follow up in Children and Adolescents with
Hinderliter, A.; Orringer, E.P. Pulmonary Hypertension in Patients Sickle Cell Anemia. Haematologica, 2011, 96, 33–40.
with Sickle Cell Disease: A Longitudinal Study. Br. J. Haematol., [28] Gore, S. Study of Prevalence of Pulmonary Hypertension in
2006, 134, 109–15. Children with Sickle Cell Anemia or Sickle Cell Disease. Joint
[12] Castro, O.; Gladwin, M.T. Pulmonary Hypertension in Sickle Cell Event Pediatr. Nutr. Prim. Healthc. Nurs., 2018, 8, 42.
Disease: Mechanisms, Diagnosis, and Management. Hematol. [29] Hagar, R.W.; Michlitsch, J.G.; Gardner, J.; Vichinsky, E.P.;
Oncol. Clin. North. Am., 2005, 19, 881–96. Morris, C.R. Clinical Differences between Children and Adults
[13] Allen, K.Y.; Jones, S.; Jackson, T.; DeCost, G.; Stephens, P.; with Pulmonary Hypertension and Sickle Cell Disease. Br. J.
Hanna, B.D.; Cohen, M.S; Smith-Whitley, K.; Mercer-Rosa, L.; Haematol., 2017, 140, 104-112
Natarajan, S.S. Echocardiographic Screening of Cardiovascular [30] Hebson, C.; New, T.; Record, E.; Oster, M.; Ehrlich, A.; Border,
Status in Pediatric Sickle Cell Disease. Pediatr. Cardiol., 2019, 40, W.; James-Herry, A.; Kanaan, U. Elevated Tricuspid Regurgitant
1670–8. Velocity as a Marker for Pulmonary Hypertension in Children with
[14] Ambrusko, S.J.; Gunawardena, S.; Sakara, A.; Windsor, B.; Sickle Cell Disease: Less Prevalent and Predictive than Previously
Lanford, L.; Michelson, P.; Krishnamurti, L. Elevation of Tricuspid Thought? J. Pediatr. Hematol. Oncol., 2015, 37, 134–9.
Regurgitant Jet Velocity, a Marker for Pulmonary Hypertension in [31] Jesus-Rojas, W.; Mosquera, R.A.; DaCosta, C.; Stark, C.K.;
Children with Sickle Cell Disease. Pediatr. Blood Cancer, 2006, Jon, K.; McBeth, A.; Yadav, A,; Houston, T.X. Screening of
47, 907–13. Pulmonary Hypertension in a Cohort of Children with Sickle Cell
[15] Chinawa, J.M.; Chukwu, B.F.; Chinawa, A.T.; Ossai, E.N.; Disease. In: A62. Sickle Cell Disease. American Thoracic Society,
Ikefuna, A.N.; Aronu, A.E.; Obidike, E.O. Right Ventricular New York, 2018. pA2057.
Function among South East Nigeria Children with Sickle Cell [32] Lamina, M.O.; Animasahun, B.A.; Akinwumi, I.N.; Njokanma, O.F.
Anaemia. BMC Pediatr., 2020, 20, 1. Doppler Echocardiographic Assessment of Pulmonary Artery
[16] Colombatti, R.; Maschietto, N.; Varotto, E.; Grison, A.; Pressure in Children with Sickle Cell Anaemia. Cardiovasc. Diag.
Grazzina, N.; Meneghello, L.; Teso, S.; Carli, M.; Milanesi, O.; Ther., 2019, 9, 204–13.
Sainati, L. Pulmonary Hypertension in Sickle Cell Disease [33] Liem, R.I.; Young, L.T.; Thompson, A.A. Tricuspid Regurgitant
Children Under 10 Years of Age: Pulmonary Hypertension in SCD Jet Velocity is Associated with Hemolysis in Children and
Patients Under 10 Years Old. Br. J. Haematol., 2010, 150, 601–9. Young Adults with sickle Cell Disease Evaluated for Pulmonary
[17] Moher, D.; Liberati, A.; Tetzlaff, J.; Altman, D.G. Preferred Hypertension. Haematologica, 2007, 92, 1549–52.
Reporting Items for Systematic Reviews and Meta-Analyses: The [34] Liem, R.I.; Nevin, M.A.; Prestridge, A.; Young, L.T.;
PRISMA Statement. Int. J. Surg., 2010, 8, 336–41. Thompson, A.A. Tricuspid Regurgitant Jet Velocity Elevation and
[18] Peterson, J.; Welch, V.; Losos, M.; Tugwell, P. The Newcastle- its Relationship to Lung Function in Pediatric Sickle Cell Disease.
Ottawa scale (NOS) for Assessing the Quality of Nonrandomised Pediatr. Pulmonol., 2009, 44, 281–9.
Studies in Meta-Analyses. Ottawa Hospital Research Institute, [35] Minniti, C.P.; Sable, C.; Campbell, A.; Rana, S.; Ensing, G.; Dham,
Ottawa, 2011. N.; Onyekwere, O.; Nouraie, M.; Kato, G.J.; Gladwin, M.T.;
[19] Nyaga, V.N.; Arbyn, M.; Aerts, M.; Metaprop: A Stata Command Castro, O.L.; Gordeuk, V.R. Elevated Tricuspid Regurgitant
to Perform Meta-Analysis of Binomial Data. Arch. Public Health, Jet Velocity in Children and Adolescents with Sickle cell
2014, 72, 39. Disease: Association with Hemolysis and Hemoglobin Oxygen
[20] Higgins, J.P.; Green, S. editors. Cochrane Handbook for Systematic Desaturation. Haematologica, 2009, 94, 340–7.
Reviews of Interventions. John Wiley and Sons, United States, [36] Molavi, M.A.; Rajaei, S.; Elahi, Z.; Nazemi, A.; Zare, S. Evaluation
2011. of Tricuspid Regurgitation Jet Velocity in Children with Sickle Cell
[21] Egger, M.; Smith, G.D.; Schneider, M.; Minder, C. Bias in Meta- Disease in Iran 2012-2013. Adv. Biores., 2015, 6, 211.
Analysis Detected by a Simple, Graphical Test. BMJ, 1997, 315, [37] Mondal, P.; Stefek, B.; Sinharoy, A.; Sankoorikal, B.J.; Abu-
629–34. Hasan, M.; Aluquin, V. The Association of Nocturnal Hypoxia
[22] Agha, H.; El Tagui, M.; El Ghamrawy, M.; Hady, M.A. The and an Echocardiographic Measure of Pulmonary Hypertension in
6-Min Walk Test: An Independent Correlate of Elevated Tricuspid Children with Sickle Cell Disease. Pediatr. Res., 2019, 85, 506–10.
Regurgitant Jet Velocity in Children and Young Adult Sickle Cell [38] Nelson, S.C.; Adade, B.B.; McDonough, E.A.; Moquist, K.L.;
Patients. Ann. Hematol., 2014, 93, 1131–8. Hennessy, J.M. High Prevalence of Pulmonary Hypertension in
[23] Cox, S.E.; Soka, D.; Kirkham, F.J.; Newton, C.R.; Prentice, A.M.; Children with Sickle Cell Disease. J. Pediatr. Hematol. Oncol.,

©2023 AccScience Publishing